Tuesday, October 26, 2021: 2:45 PM-4:45 PM
Butler (Rosen Shingle Creek)
2:45 PM
Development and Usability Testing of a Patient-Based Digital Tool to Detect Early Signs of Changes in Multiple Sclerosis Symptoms and Progression: Your MS Questionnaire
Tjalf Ziemssen, MD, PhD, Department of Neurology, University Clinic Carl-Gustav Carus;
Enrique Alvarez, MD, PhD, University of Colorado School of Medicine;
Virender Bhan, MD, University of British Columbia;
Jason Burton, MBBS, Centre for Neuromuscular and Neurological Disorders, Western Australian Neuroscience Research Institute, The University of Western Australia;
Olaf Hoffmann, PD Dr. med., Department of Neurology, Alexianer St. Josefs Hospital;
Celia Oreja-Guevara, MD, Department of Neurology, University Hospital San Carlos, Idissc;
René Robles-Cedeño, MD, PhD, Neuroimmonology and Multiple Sclerosis Unit;
Maria Trojano, MD, University of Bari;
Patrick Vermersch, MD, PhD, Univ. Lille, Inserm U1172, CHU Lille, FHU Precise;
Salvatore Napoli, MD, Partners, Multiple Sclerosis Center, and Center for Neurological Imaging, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School;
Augusto Miravalle, MD, Department of Neurology, University of Colorado;
Yan Xu, MD, PhD, Multiple Sclerosis Center, Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences;
Jo Vandercappellen, PhD, MBA, Novartis Pharma AG;
Mudeer Khwaja, BSc, Novartis Pharma AG;
Mark Marchaterre, IT BS, Novartis Services Inc., East Hanover;
Bianca Stadler, PhD, Novartis Pharma GmbH;
Thomas Hach, MD, Novartis Pharma AG;
Gavin Giovannoni, MD, PhD, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
3:00 PM
COVID-19 in Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease Patients in North America
Scott D. Newsome, DO, MSCS, FAAN, FANA, Johns Hopkins University School of Medicine;
Anne H. Cross, MD, Washington University School of Medicine;
Robert J. Fox, MD, Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic;
June Halper, MSN, APN-C, MSCN, FAAN, Consortium of Multiple Sclerosis Centers;
Pamela Kanellis, PhD, MS Society of Canada;
Bruce Bebo, PhD, National Multiple Sclerosis Society;
David KB Li, MD FRCPC, University of British Columbia;
Gary Cutter, PhD, University of Alabama at Birmingham;
Kottil Rammohan, MD, Multiple Sclerosis Center, University of Miami;
Amber Salter, PhD, UT Southwestern Medical Center
3:15 PM
How the COVID-19 Pandemic Has Changed Multiple Sclerosis Clinical Practice: Results of a Nationwide Provider Survey
Elizabeth H Morrison, MD, MSEd, University of California, Riverside School of Medicine;
Katelyn Michtich, MBA, National Multiple Sclerosis Society, Southern California & Nevada Chapter;
Carrie M Hersh, DO, MS, Cleveland Clinic, Lou Ruvo Center for Brain Health
3:30 PM
Characterizing Socioeconomic, Lifestyle, and Comorbidity Mediators of Racial Disparities in Ambulatory Impairments in Multiple Sclerosis.
Farren B.S. Briggs, PhD, ScM, Case Western Reserve University School of Medicine;
Erika S. Trapl, PhD, Case Western Reserve University School of Medicine;
Devon Conway, MD, MS, Cleveland Clinic Foundation;
Douglas D. Gunzler, PhD, Case Western Reserve University School of Medicine
3:45 PM
Optical Coherence Tomography As a Biomarker for Multiple Sclerosis Studies
Grace Levy-Clarke, MD, Tampa Bay Uveitis Center, LLC;
Carrie Levy, PhD, Tampa Bay Uveitis Center, LLC;
Gregory Flippen, DO, Tampa Bay Uveitis Center, LLC;
Lauren David, Study Coordinator, Tampa Bay Uveitis Center, LLC;
Edouard-Hugh Clarke, JD, Tampa Bay Uveitis Center, LLC;
Mark Cascione, MD, Tampa Neurology Associates
4:00 PM
Associations of Structural Visual Metrics with Moderate to Vigorous Physical Activity in Youth with Pediatric Onset Neuroinflammatory Disorders
Juweiriya Ahmed, MSc, The Hospital for Sick Children;
Samantha Stephens, PhD, The Hospital for Sick Children;
Mina Ly, BSc, MSc, The Hospital for Sick Children;
Giulia Longoni, MD, The Hospital for Sick Children;
E. Ann Yeh, MD, MA, FRCPC, Dip ABPN, The Hospital for Sick Children
4:15 PM
Treating Minority Patients with Multiple Sclerosis: Development of the CHIMES Trial
Mitzi J Williams, MD, Joi Life Wellness MS Center;
Lilyana Amezcua, MD, University of Southern California;
Timothy Vartanian, MD, PhD, Weill Cornell Medicine;
Gregory F Wu, MD, PhD, Washington University in St. Louis;
Nancy L Monson, PhD, UT Southwestern Medical Center;
Evanthia Bernitsas, MD, Wayne State University School of Medicine;
Christopher Harp, PhD, Genentech, Inc.;
Xiaoming Jia, MD, MEng, Genentech, Inc.;
Jinglan Pei, PhD, Genentech, Inc.;
Juan Acosta, MD, Genentech, Inc.;
Fabio Magrini, MD, Genentech, Inc.;
Anthony T Reder, MD, University of Chicago Neurology
4:30 PM
Prevalence of Cannabis Use and Associated Factors Among People with Multiple Sclerosis: A 2020 NARCOMS Survey
Robert J. Fox, MD, Mellen Center for Multiple Sclerosis, Cleveland Clinic;
Amber Salter, PhD, Washington University School in St. Louis;
Gary Cutter, PhD, The University of Alabama at Birmingham;
Kate Nichol, PhD, Greenwich Biosciences, Inc.;
Joshua R. Steinerman, MD, Greenwich Biosciences, Inc.;
Karry Smith, PhD, MPH, Greenwich Biosciences, Inc.
